Opus Genetics IRD
NASDAQ IRD
$5.07 +0.11 (+2.22%)
As of: Sep 30, 2026 · 12:51 PM EDT

Opus Genetics, Inc. (IRD) Current Deferred Revenue (2019 - 2020)

Updated

Opus Genetics (IRD) reported Current Deferred Revenue of $650,000 for Q3 2020, down 56.7% from $1.5 million a year earlier and unchanged from the prior quarter.

Analysis

Opus Genetics, Inc. (IRD) Current Deferred Revenue (2019 - 2020) Analysis & Trends

At the end of FY2019, Opus Genetics posted Current Deferred Revenue of $1.5 million.

  • Five-year quarterly Current Deferred Revenue spans a low of $150,000 in Q1 2019 and a high of $1.5 million in Q4 2019.
  • Per Business Quant data, the three quarters before Q3 2020 came in at $650,000 (Q2 2020), $600,000 (Q1 2020) and $1.5 million (Q4 2019).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 650,000.00
Jun 30, 2020 650,000.00
Mar 31, 2020 600,000.00
Dec 31, 2019 1.50 Mn
Sep 30, 2019 1.50 Mn
Jun 30, 2019 1.50 Mn
Mar 31, 2019 150,000.00
API Access

Opus Genetics, Inc. Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=IRD&period=max&api_key=YOUR_API_KEY